Press Release: From News&Views April 2019: The Biologics Price Competition and Innovation Act (BPCIA) of 2009 created an FDA approval pathway for biosimilars that aimed to expanded patient access to these more affordable therapies.

AMCP webinar that reviewed proceedings from this Partnership Forum.

AMCP webinar that reviewed the major provisions contained in a recently released advanced notice of proposed rulemaking from CMS on the International Drug Pricing Index for Part B drugs and a recently proposed rule on the Medicare Advantage and Part D Program.

AMCP webinar that provided tips on how to prepare for the ASHP Midyear.

AMCP webinar that reviewed a summary of discussions from this summit.

AMCP webinar that reviewed proceedings from this Partnership Forum.

The Academy of Managed Care Pharmacy (AMCP) appreciates the opportunity to provide information on the application of value-based contracts (VBCs) for insulin pricing initiatives. The shift in payment models is expanding beyond the delivery of health care services to encompass models of compensation between payers and biopharmaceutical manufacturers.

This is a presentation from the AMCP’s Partnership Forum webnar that explored the VBC expansion. The described the creation of a consensus definition and guiding principles for value-based contracts; strategies for evaluating, implementing and monitoring VBC’s, and recommendations for mitigating legal and regulatory barriers to VBCs.